4.7 Review

Novel Biorecognition Elements against Pathogens in the Design of State-of-the-Art Diagnostics

Journal

BIOSENSORS-BASEL
Volume 11, Issue 11, Pages -

Publisher

MDPI
DOI: 10.3390/bios11110418

Keywords

biorecognition; diagnosis; biosensor; pathogens; aptamers; antibodies; peptides; enzymes; DNAzymes; peptide nucleic acids

Funding

  1. EU Horizon 2020 Research and Innovation Programme under the Marie Sklowdowska-Curie Grant [765042]
  2. Fundacao para a Ciencia e Tecnologia (FCT) [UID/BIO/04469/2020]
  3. European Social Fund
  4. Marie Curie Actions (MSCA) [765042] Funding Source: Marie Curie Actions (MSCA)

Ask authors/readers for more resources

Infectious agents, especially bacteria and viruses, are responsible for a vast number of hospitalizations and deaths worldwide. Conventional diagnostic solutions, while technologically advanced, are often complex and inaccessible in resource-limited settings. Therefore, there is a need for convenient and rapid diagnostics with reliability, which can be easily administered at low cost.
Infectious agents, especially bacteria and viruses, account for a vast number of hospitalisations and mortality worldwide. Providing effective and timely diagnostics for the multiplicity of infectious diseases is challenging. Conventional diagnostic solutions, although technologically advanced, are highly complex and often inaccessible in resource-limited settings. An alternative strategy involves convenient rapid diagnostics which can be easily administered at the point-of-care (POC) and at low cost without sacrificing reliability. Biosensors and other rapid POC diagnostic tools which require biorecognition elements to precisely identify the causative pathogen are being developed. The effectiveness of these devices is highly dependent on their biorecognition capabilities. Naturally occurring biorecognition elements include antibodies, bacteriophages and enzymes. Recently, modified molecules such as DNAzymes, peptide nucleic acids and molecules which suffer a selective screening like aptamers and peptides are gaining interest for their biorecognition capabilities and other advantages over purely natural ones, such as robustness and lower production costs. Antimicrobials with a broad-spectrum activity against pathogens, such as antibiotics, are also used in dual diagnostic and therapeutic strategies. Other successful pathogen identification strategies use chemical ligands, molecularly imprinted polymers and Clustered Regularly Interspaced Short Palindromic Repeats-associated nuclease. Herein, the latest developments regarding biorecognition elements and strategies to use them in the design of new biosensors for pathogens detection are reviewed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available